| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |